Working to cure cancer
We are focused on building new therapies for cancer treatment. We identify novel cancer antigens and generate antibodies and cell therapies to target the cancer antigens.
Our latest publication detailing the development of bispecific antibodies that selectively kill T cell cancers and do not harm the normal human T cells.
Science Translational Medicine 2021